THE Health Department has released the draft report for the post-market review of Pulmonary Aterial Hypertension (PAH) Medicines, which is open for public comment until 10 Jun 2018.
More details at pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 May 18